4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-011331
SVP, Chief Accounting Officer sold 1,829 shares at $7.45 ($13,631)
- SVP, Chief Accounting Officer acquired 25,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabatini Brent SVP, Chief Accounting Officer | 2026-02-22 | Grant or award 10b5-1 | +25,000 | 72,872 | D | ||
| Sabatini Brent SVP, Chief Accounting Officer | 2026-02-23 | Sale 10b5-1 | −1,829 | $7.45 | $13,631 | 71,043 | D |
| Derivatives | |||||||
| Sabatini Brent SVP, Chief Accounting Officer | 2026-02-22 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +50,000 | 50,000 | D | ||
| Open-market sales · 1,829 sh · avg $7.45 · $13,631 | |||||||
Loading xslF345X05/wk-form4_1771978411.xml…